Suppr超能文献

Fontan手术后的起搏器治疗——一项瑞典全国性研究。

Pacemaker treatment after Fontan surgery-A Swedish national study.

作者信息

Alenius Dahlqvist Jenny, Sunnegårdh Jan, Hanséus Katarina, Strömvall Larsson Eva, Nygren Anders, Dalén Magnus, Berggren Håkan, Johansson Ramgren Jens, Wiklund Urban, Rydberg Annika

机构信息

Department of Clinical Sciences, Umeå University, Umeå, Sweden.

Department of Cardiology, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden.

出版信息

Congenit Heart Dis. 2019 Jul;14(4):582-589. doi: 10.1111/chd.12766. Epub 2019 Mar 18.

Abstract

OBJECTIVE

Fontan surgery is performed in children with univentricular heart defects. Previous data regarding permanent pacemaker implantation frequency and indications in Fontan patients are limited and conflicting. We examined the prevalence of and risk factors for pacemaker treatment in a consecutive national cohort of patients after Fontan surgery in Sweden.

METHODS

We retrospectively reviewed all Swedish patients who underwent Fontan surgery from 1982 to 2017 (n = 599).

RESULTS

After a mean follow-up of 12.2 years, 13% (78/599) of the patients with Fontan circulation had received pacemakers. Patients operated with the extracardiac conduit (EC) type of total cavopulmonary connection had a significantly lower prevalence of pacemaker implantation (6%) than patients with lateral tunnel (LT; 17%). Mortality did not differ between patients with (8%) and without pacemaker (5%). The most common pacemaker indication was sinus node dysfunction (SND) (64%). Pacemaker implantation due to SND was less common among patients with EC. Pacemaker implantation was significantly more common in patients with mitral atresia (MA; 44%), double outlet right ventricle (DORV; 24%) and double inlet left ventricle (DILV; 20%). In contrast, patients with pulmonary atresia with intact ventricular septum and hypoplastic left heart syndrome were significantly less likely to receive a pacemaker (3% and 6%, respectively).

CONCLUSIONS

Thirteen percent of Fontan patients received a permanent pacemaker, most frequently due to SND. EC was associated with a significantly lower prevalence of pacemaker than LT. Permanent pacemaker was more common in patients with MA, DORV, and DILV.

摘要

目的

单心室心脏缺陷患儿需接受Fontan手术。此前关于Fontan患者永久性起搏器植入频率及指征的数据有限且存在矛盾。我们调查了瑞典全国连续队列中Fontan手术后患者起搏器治疗的患病率及危险因素。

方法

我们回顾性分析了1982年至2017年在瑞典接受Fontan手术的所有患者(n = 599)。

结果

平均随访12.2年后,Fontan循环患者中有13%(78/599)接受了起搏器治疗。采用心外管道(EC)型全腔静脉肺动脉连接术的患者起搏器植入率(6%)显著低于采用侧隧道(LT)型的患者(17%)。有起搏器治疗的患者死亡率(8%)与未接受起搏器治疗的患者(5%)无差异。最常见的起搏器植入指征是窦房结功能障碍(SND)(64%)。因SND植入起搏器在EC患者中较少见。二尖瓣闭锁(MA)、右心室双出口(DORV)和左心室双入口(DILV)患者中起搏器植入明显更常见。相比之下室间隔完整的肺动脉闭锁和左心发育不全综合征患者接受起搏器治疗的可能性显著降低(分别为3%和6%)。

结论

13%的Fontan患者接受了永久性起搏器治疗,最常见原因是SND。与LT相比,EC与显著更低的起搏器植入率相关。MA、DORV和DILV患者中永久性起搏器更常见。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验